Dishman Carbogen Amcis Limited — Important, 24-03-2025: General Updates

CARBOGEN AMCIS, a wholly-owned subsidiary of Dishman Carbogen Amcis Ltd., has secured GMP certification for its Saint-Beauzire, France site following a successful inspection by the French regulatory authority, ANSM. This certification, granted on March 19, signifies the facility’s compliance with Good Manufacturing Practices and enables the manufacture of clinical and commercial sterile drug products. The state-of-the-art site, which opened in early 2023 at an investment of €60 million, boosts CARBOGEN's capabilities in sterile drug production, enhancing its value as a partner in the pharmaceutical sector. This achievement may foster a positive investor outlook by strengthening the company's market position and operational capabilities.